Nordic MDS-group

Introduction
Coordinators
Members
Studies
Publications
Diagnosis and prognosis
Nordic Care Programme
Meeting Calendar
Contact information

Patient informations

Danish 
Finish 
Icelandic 
Norwegian 
Swedish 

Members only

User name:  

Password:  

2005

»» Long term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. M Jädersten, Scott M. Montgomery, Ingunn Dybedal, Anna Porwit-MacDonald and Eva Hellström-Lindberg. Clinical observations, interventions and therapeutic trials. Blood 1 August 2005.Volym 106, Number 3.

Article for download

2004

»» The WHO classification of MDS does make a difference.
Robert B.Howe, Anna Porwit-McDonald,Robert Wanat, Ramin Tehranchi and Eva Hellström-Lindberg.Blood May 1 2004. Volume 103, Number 9.

Article for download

2003

»» A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony stimulating factor: significant effects on quality of life.
Eva Hellström-Lindberg et al. British Journal of Hematology, 2003.

Article for download

»» No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.
Robert Hast et al. Leukemia 2003

Article for download

Current news

Next NMDSG meeting
[2008-05-13]
will be held in
Stockholm, Nov 21-22

Meeting Minutes
[2008-05-13]
from the Nordic MDS
Group meeting
2008-04-25

Meeting agenda
[2008-04-24]
Welcome 25 April,
please see final agenda
(PDF document)

Invitation to meeting
[2008-03-06]
News, invitation to
meeting and information

Meeting Minutes
[2007-12-07]
from the Nordic MDS
Group meeting
2007-11-15-16

Lenalidomide
study information
[2007-12-06]